Redeye retains its positive view of Carasent following the Q4 report.
Redeye updates its Base Case and forecasts following Fortnox’s Q4 report, with sales and EBIT matchi...
Redeye provides an update following SSH's Q4 2024 report.
Sales better than expected, adj. EBITDA in line We leave our estimates relatively unchanged Still po...
'25e-'26e EBITA down 7-5% Freight rate normalisation required for better gross margins '25e EV/EBITA...
Redeye strengthens its positive view of CombinedX following a solid Q4 considering the soft market.
Alisa Bank’s H2 financials corresponded to our expectations, although NII and subsequently total inc...
On February 14, 2025, Nosa Plugs published the company’s interim report for the fourth quarter of 20...
Solteq’s Q4 results were weaker than expected. While the company maintained its profitability improv...
Raute has already achieved high results, and they could be even higher in a more favorable market en...
CapMan’s Q4 results were better than expected through good investment returns.
Finnair’s results were very strong for Q4 after some more challenging quarters last year.
Small signs pointing towards a system-wide deal in India At the presentation of the Q4’24 report, C...
Endomines is progressing well in line with its strategy and the H2/24 was clear evidence of the comp...
Umida Group publicerade den 13 februari 2025 bolagets delårsrapport för det fjärde kvartalet år 2024...
EBIT in line with preliminary figures, sales slightly above Formpipe has taken measures to enhance m...
Redeye comments on Formpipe’s Q4, with a soft adjusted EBIT as previously announced.
Redeye states Acconeer’s net sales came in below expectations, driven by a postponement of a prepaid...
Redeye's provides its initial take on Genovis' year-end report which came in softer than we had esti...
Redeye provides an initial comment on Safeture’s Q4 2024 report, which showed slower ARR growth than...
